ESR1 and breast cancer: Breast cancer is a heterogeneous disease that includes a particular subtype, the triple negative breast cancer (TNBC) subtype, characterized by lack of immunohistochemistry (IHC) staining for estrogen receptor (ER), progesterone receptor (PR), and HER2 receptors1.